Here, we report that a novel inhibitor of S100A4 can specifically block its increase in cell migration in rat (IC50, 46 μM) and human (56 μM) triple negative breast cancer (TNBC) cells without affecting Western-blotted levels of S100A4. This evidence concerns the gene S100A4 and triple-negative breast carcinoma.